BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37124531)

  • 1. A novel preclinical model of craniospinal irradiation in pediatric diffuse midline glioma demonstrates decreased metastatic disease.
    Knox AJ; Van Court B; Oweida A; Barsh E; DeSisto J; Flannery P; Lemma R; Chatwin H; Vibhakar R; Dorris K; Serkova NJ; Karam SD; Gilani A; Green AL
    Front Oncol; 2023; 13():1105395. PubMed ID: 37124531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric midline H3K27M-mutant tumor with disseminated leptomeningeal disease and glioneuronal features: case report and literature review.
    Navarro RE; Golub D; Hill T; McQuinn MW; William C; Zagzag D; Hidalgo ET
    Childs Nerv Syst; 2021 Jul; 37(7):2347-2356. PubMed ID: 32989496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vulnerability of white matter to insult during childhood: evidence from patients treated for medulloblastoma.
    Moxon-Emre I; Bouffet E; Taylor MD; Laperriere N; Sharpe MB; Laughlin S; Bartels U; Scantlebury N; Law N; Malkin D; Skocic J; Richard L; Mabbott DJ
    J Neurosurg Pediatr; 2016 Jul; 18(1):29-40. PubMed ID: 27015518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Craniospinal irradiation with concurrent temozolomide for primary metastatic pediatric high-grade or diffuse intrinsic pontine gliomas. A first report from the GPOH-HIT-HGG Study Group.
    Müller K; Schlamann A; Guckenberger M; Warmuth-Metz M; Glück A; Pietschmann S; Wawer A; Kortmann RD; Kramm C; von Bueren AO
    Strahlenther Onkol; 2014 Apr; 190(4):377-81. PubMed ID: 24638239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival and neurocognitive outcomes after cranial or craniospinal irradiation plus total-body irradiation before stem cell transplantation in pediatric leukemia patients with central nervous system involvement.
    Hiniker SM; Agarwal R; Modlin LA; Gray CC; Harris JP; Million L; Kiamanesh EF; Donaldson SS
    Int J Radiat Oncol Biol Phys; 2014 May; 89(1):67-74. PubMed ID: 24725690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical Models of Craniospinal Irradiation for Medulloblastoma.
    Stripay JL; Merchant TE; Roussel MF; Tinkle CL
    Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31948065
    [No Abstract]   [Full Text] [Related]  

  • 7. Craniospinal irradiation for treatment of metastatic pediatric low-grade glioma.
    Tsang DS; Murphy ES; Ezell SE; Lucas JT; Tinkle C; Merchant TE
    J Neurooncol; 2017 Sep; 134(2):317-324. PubMed ID: 28623604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced-dose craniospinal irradiation for central nervous system relapsed neuroblastoma.
    Luo LY; Kramer K; Cheung NV; Kushner BH; Modak S; Basu EM; Roberts SS; Wolden SL
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28364. PubMed ID: 32608559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel CDK4/6 inhibitor combined with irradiation demonstrates potent anti-tumor efficacy in diffuse midline glioma.
    Zuo P; Li Y; Wang T; Lin X; Wu Z; Zhang J; Liao X; Zhang L
    J Neurooncol; 2023 May; 163(1):159-171. PubMed ID: 37133743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiosensitisation by olaparib through focused ultrasound delivery in a diffuse midline glioma model.
    't Hart E; Bianco J; Bruin MAC; Derieppe M; Besse HC; Berkhout K; Chin Joe Kie LA; Su Y; Hoving EW; Huitema ADR; Ries MG; van Vuurden DG
    J Control Release; 2023 May; 357():287-298. PubMed ID: 37019285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Parotid Gland is an Underrecognized Organ at Risk for Craniospinal Irradiation.
    King MT; Modlin L; Million L; Donaldson SS; Gibbs IC; Choi CY; Soltys SG
    Technol Cancer Res Treat; 2016 Jun; 15(3):472-9. PubMed ID: 25948323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current perspectives on diffuse midline glioma and a different role for the immune microenvironment compared to glioblastoma.
    Pachocki CJ; Hol EM
    J Neuroinflammation; 2022 Nov; 19(1):276. PubMed ID: 36403059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venetoclax Cooperates with Ionizing Radiation to Attenuate Diffuse Midline Glioma Tumor Growth.
    Madhavan K; Balakrishnan I; Lakshmanachetty S; Pierce A; Sanford B; Fosmire S; Elajaili HB; Walker F; Wang D; Nozik ES; Mitra SS; Dahl NA; Vibhakar R; Venkataraman S
    Clin Cancer Res; 2022 Jun; 28(11):2409-2424. PubMed ID: 35344040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage craniospinal irradiation with an intensity modulated radiotherapy technique for patients with disseminated neuraxis disease.
    Wei RL; Nguyen ST; Yang JN; Wolff J; Mahajan A
    Pract Radiat Oncol; 2012; 2(4):e69-e75. PubMed ID: 24674188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized disease.
    Calaminus G; Kortmann R; Worch J; Nicholson JC; Alapetite C; Garrè ML; Patte C; Ricardi U; Saran F; Frappaz D
    Neuro Oncol; 2013 Jun; 15(6):788-96. PubMed ID: 23460321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Craniospinal irradiation with concurrent temozolomide and nimotuzumab in a child with primary metastatic diffuse intrinsic pontine glioma. A compassionate use treatment.
    Müller K; Schlamann A; Seidel C; Warmuth-Metz M; Christiansen H; Vordermark D; Kortmann RD; Kramm CM; von Bueren AO
    Strahlenther Onkol; 2013 Aug; 189(8):693-6. PubMed ID: 23754473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced-dose craniospinal irradiation is feasible for standard-risk adult medulloblastoma patients.
    Massimino M; Sunyach MP; Barretta F; Gandola L; Garegnani A; Pecori E; Spreafico F; Bonneville-Levard A; Meyronet D; Mottolese C; Boschetti L; Biassoni V; Schiavello E; Giussani C; Carrabba G; Diletto B; Pallotti F; Stefini R; Ferrari A; Terenziani M; Casanova M; Luksch R; Meazza C; Podda M; Chiaravalli S; Puma N; Bergamaschi L; Morosi C; Calareso G; Giangaspero F; Antonelli M; Buttarelli FR; Frappaz D
    J Neurooncol; 2020 Jul; 148(3):619-628. PubMed ID: 32567042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Korean Society for Neuro-Oncology (KSNO) Guideline for Adult Diffuse Midline Glioma: Version 2021.1.
    Yoon HI; Wee CW; Kim YZ; Seo Y; Im JH; Dho YS; Kim KH; Hong JB; Park JS; Choi SH; Kim MS; Moon J; Hwang K; Park JE; Cho JM; Yoon WS; Kim SH; Kim YI; Kim HS; Sung KS; Song JH; Lee MH; Han MH; Lee SH; Chang JH; Lim DH; Park CK; Lee YS; Gwak HS;
    Brain Tumor Res Treat; 2021 Apr; 9(1):1-8. PubMed ID: 33913265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional cranio-spinal irradiation: A hippocampal and hypothalamic-pituitary axis sparing radiation technique using two IMRT modalities.
    Zheng J; Aljabab S; Lacasse P; Bahm J; Lekx-Toniolo K; Grimard L
    Med Dosim; 2020 Summer; 45(2):190-196. PubMed ID: 31843470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining tumor-associated vascular heterogeneity in pediatric high-grade and diffuse midline gliomas.
    Wei X; Meel MH; Breur M; Bugiani M; Hulleman E; Phoenix TN
    Acta Neuropathol Commun; 2021 Aug; 9(1):142. PubMed ID: 34425907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.